Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients ...Middle East

GALWAY, Ireland and CHICAGO, March 30, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut™ transcatheter aortic valve...

Read More Details
Finally We wish PressBee provided you with enough information of ( Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients )

Also on site :

• Oil prices up after reports of 3 ships on fire in Gulf of Oman near the strait of Hormuz
• Ron Taylor Passes Away
• Padres Select Bryce Johnson